Burns Trauma 11 , tkad033 (2023)
Gomez D, Byers L, Diao L, Nilsson M, Wang J, Saigal B, Wistuba I, Suraokar M, Moran C, Kalhor N, |BSwisher S , Fan Y, Hong W, Behrens C, Heymach J
B12 corrects deficiency-driven metabolic slowdown but does not accelerate metabolism beyond normal function
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors to promote weight loss and improve blood sugar control in obesity and type 2 diabetes
What the Data Shows GLP-1 receptors are expressed throughout the mesolimbic dopamine pathway the brain's reward circuitry
This effect immediately suggested that chemical agonists similar to GLP-1 could be effective drugs to treat type 2 diabetes